Covered recipient · General Payments record
ANTHONIA OKOYEUZU
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2025
$474.60
- Reported across 15 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $474.60 | 15 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $289.13 | 11 |
| RECORDATI_RARE_DISEASES_INC. | $132.89 | 1 |
| Lilly USA, LLC | $20.79 | 1 |
| DEXCOM, INC. | $16.12 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.67 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $474.60 | 15 |
Payment records · PY2025 (15)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Dexcom, Inc. | $16.12 | 11/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250544120 | CMS |
| Lilly USA, LLC | $20.79 | 07/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186994420 | CMS |
| Novartis Pharmaceuticals Corporation | $15.67 | 09/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200773833 | CMS |
| Novo Nordisk Inc | $19.60 | 05/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188488225 | CMS |
| Novo Nordisk Inc | $15.46 | 06/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188563990 | CMS |
| Novo Nordisk Inc | $113.63 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189083503 | CMS |
| Novo Nordisk Inc | $22.68 | 07/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188749829 | CMS |
| Novo Nordisk Inc | $19.04 | 07/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188260731 | CMS |
| Novo Nordisk Inc | $22.42 | 08/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189044844 | CMS |
| Novo Nordisk Inc | $18.48 | 09/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188335851 | CMS |
| Novo Nordisk Inc | $15.88 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189149708 | CMS |
| Novo Nordisk Inc | $17.52 | 10/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189000961 | CMS |
| Novo Nordisk Inc | $8.54 | 11/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188694962 | CMS |
| Novo Nordisk Inc | $15.88 | 12/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188589997 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $132.89 | 08/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181731747 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.